Product
MCO-010
Aliases
Gene Therapy product-MCO-010, Gene Therapy Product-MCO-010
3 clinical trials
8 indications
Indication
Retinitis PigmentosaIndication
RetinitisIndication
Retinal DiseasesIndication
Eye DisordersIndication
HereditaryIndication
Retinal DystrophiesIndication
retinal degenerationIndication
Stargardt DiseaseClinical trial
A Phase 2b Randomized, Double-Masked, Sham-Controlled, Study to Evaluate the Efficacy and Safety of Intravitreal Injection of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]Status: Completed, Estimated PCD: 2023-02-27
Clinical trial
Long Term Follow-up for Subjects Who Previously Participated in the NTXMCO-002 RESTORE StudyStatus: , Estimated PCD: 2027-07-01
Clinical trial
Long Term Follow-up for Participants Who Previously Received a Single Intravitreal Injection of MCO-010 Optogenetic Therapy in the STARLIGHT StudyStatus: , Estimated PCD: 2027-05-01